What is Myotronics?
Myotronics operates at the intersection of dental medicine and advanced diagnostic technology. The company provides a sophisticated suite of tools, including the K7 Evaluation System and the J5 Dental TENS unit, which are essential for practitioners diagnosing and treating complex conditions such as temporomandibular disorders and sleep apnea. Beyond hardware, Myotronics distinguishes itself through a comprehensive educational ecosystem, offering specialized training that empowers dental professionals to expand their clinical capabilities and optimize practice revenue. By bridging the gap between technical innovation and clinical application, the company serves a critical role in modernizing patient care standards for dental practices globally.
How much funding has Myotronics raised?
Myotronics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Myotronics
PPP
Public-Private Partnership
What's next for Myotronics?
With the recent influx of capital, Myotronics is poised to scale its operational footprint and deepen its penetration into the global sleep medicine market. The strategic roadmap likely involves expanding its educational outreach programs and enhancing its R&D pipeline to maintain a competitive edge in neuromuscular diagnostics. As the company transitions through this late-stage growth phase, the focus will shift toward increasing market share among dental professionals who are increasingly prioritizing evidence-based, technology-driven treatment protocols. This investment serves as a catalyst for long-term sustainability and innovation in a rapidly evolving healthcare landscape.
See full Myotronics company page
